Literature DB >> 19747466

Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats.

Mieszko Olczak1, Michalina Duszczyk, Pawel Mierzejewski, Maria Dorota Majewska.   

Abstract

Thimerosal (THIM), an organomercury preservative added to many child vaccines is a suspected factor in pathogenesis of neurodevelopmental disorders. We examined the pharmacokinetics of Hg in the brain, liver and kidneys after i.m. THIM injection in suckling rats and we tested THIM effect on nociception. THIM solutions were injected to Wistar and Lewis rats in a vaccination-like mode on PN days 7, 9, 11 and 15 in four equal doses. For Wistar rats these were: 12, 48, 240, 720, 1440, 2160, 3000 microg Hg/kg and for Lewis: 54, 216, 540 and 1080 microg Hg/kg. Pharmacokinetic analysis revealed that Hg from THIM injections accumulates in the rat brain in significant amounts and remains there longer than 30 days after the injection. At the 6th week of age animals were examined for pain sensitivity using the hot plate test. THIM treated rats of both strains and sexes manifested statistically significantly elevated pain threshold (latency for paw licking, jumping) on a hot plate (56 degrees C). Wistar rats were more sensitive to this effect than Lewis rats. Protracted THIM-induced hypoalgesia was reversed by naloxone (5 mg/kg, i.p.) injected before the hot plate test, indicative of involvement of endogenous opioids. This was confirmed by augmented catalepsy after morphine (2.5 mg/kg, s.c.) injection. Acute THIM injection to 6-week-old rats also produced hypoalgesia, but this effect was transient and was gone within 14 days. Present findings show that THIM administration to suckling or adult rats impairs sensitivity to pain, apparently due to activation the endogenous opioid system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747466     DOI: 10.1016/j.brainres.2009.09.003

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Maternal thimerosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone metabolism, and motor behavior in rat pups; sex- and strain-dependent effects.

Authors:  Z L Sulkowski; T Chen; S Midha; A M Zavacki; Elizabeth M Sajdel-Sulkowska
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

2.  Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain.

Authors:  Mieszko Olczak; Michalina Duszczyk; Pawel Mierzejewski; Teresa Bobrowicz; Maria Dorota Majewska
Journal:  Neurochem Res       Date:  2010-08-28       Impact factor: 3.996

3.  Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate.

Authors:  Michalina Duszczyk-Budhathoki; Mieszko Olczak; Malgorzata Lehner; Maria Dorota Majewska
Journal:  Neurochem Res       Date:  2011-10-21       Impact factor: 3.996

Review 4.  Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines.

Authors:  José G Dórea
Journal:  Neurochem Res       Date:  2011-02-25       Impact factor: 4.414

5.  Examination of the safety of pediatric vaccine schedules in a non-human primate model: assessments of neurodevelopment, learning, and social behavior.

Authors:  Britni Curtis; Noelle Liberato; Megan Rulien; Kelly Morrisroe; Caroline Kenney; Vernon Yutuc; Clayton Ferrier; C Nathan Marti; Dorothy Mandell; Thomas M Burbacher; Gene P Sackett; Laura Hewitson
Journal:  Environ Health Perspect       Date:  2015-02-18       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.